Evidence map›Paper›PMID 33823228›Full record

ArticleFood and chemical toxicology : an international journal published for the British Industrial Biological Research Association2021

Recent efforts for drug identification from phytochemicals against SARS-CoV-2: Exploration of the chemical space to identify druggable leads.

Gaurav Joshi, Jayant Sindhu, Shikha Thakur, Abhilash Rana, Geetika Sharma, Mayank, Ramarao Poduri

Abstract read
In one paragraph

Article in Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Exploring the Antibacterial Potential ofPharmaceuticals (Basel, Switzerland) · 2024
    Article
  3. BioMed research international · 2023
    Article
  4. Article
  5. Review
  6. Antcins fromPlants (Basel, Switzerland) · 2021
    Article
  7. Phytochemicals fromBiology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Gaurav JoshiDepartment of Pharmaceutical Sciences and Natural Products, School of Health Sciences, Central University of Punjab, Bathinda, 151 401, India; School of Pharmacy, Graphic Era Hill University, Dehradun, 248171, India. Electronic address: garvpharma29@gmail.com.
Jayant SindhuDepartment of Chemistry, COBS & H, CCS Haryana Agricultural University, Hisar, 125 004 India.
Shikha ThakurDepartment of Pharmaceutical Sciences and Natural Products, School of Health Sciences, Central University of Punjab, Bathinda, 151 401, India.
Abhilash RanaAmity Institute of Biotechnology, Amity University, Sector 125 Noida, Uttar Pradesh, India.
Geetika SharmaAmity Institute of Biotechnology, Amity University, Sector 125 Noida, Uttar Pradesh, India.
MayankShobhaben Pratapbhai Patel - School of Pharmacy & Technology Management, SVKM's NMIMS University, Vile Parle, Mumbai, 400056, India. Electronic address: mayank6103@gmail.com.
Ramarao PoduriDepartment of Pharmaceutical Sciences and Natural Products, School of Health Sciences, Central University of Punjab, Bathinda, 151 401, India. Electronic address: ramaraop@yahoo.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nature, which remains a central drug discovery pool, is always looked upon to find a putative druggable lead. The natural products and phytochemical derived from plants are essential during a global health crisis. This class represents one of the most practical and promising approaches to decrease pandemic's intensity owing to their therapeutic potential. The present manuscript is therefore kept forth to give the researchers updated information on undergoing research in allied areas of natural product-based drug discovery, particularly for Covid-19 disease. The study briefly shreds evidence from in vitro and in silico researches done so far to find a lead molecule against Covid-19. Following this, we exhaustively explored the concept of chemical space and molecular similarity parameters for the drug discovery about the lead(s) generated from in silico-based studies. The comparison was drawn using FDA-approved anti-infective agents during 2015-2020 using key descriptors to evaluate druglike properties. The outcomes of results were further corroborated using Molecular Dynamics studies which suggested the outcomes in alignment with chemical space ranking. In a nutshell, current research work aims to provide a holistic strategic approach to drug design, keeping in view the identified phytochemicals against Covid-19.

Indexed as

Drug DiscoveryAngiotensin-Converting Enzyme 2Antiviral AgentsCOVID-19Host-Pathogen InteractionsHumansMolecular Dynamics SimulationMolecular StructurePhytochemicalsSARS-CoV-2Spike Glycoprotein, CoronavirusACE2 protein, humanAngiotensin-Converting Enzyme 2Antiviral AgentsPhytochemicalsSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2Chemical spaceCovid-19Druggable targetsIn silico studiesMolecular similarityNatural productsSARS-CoV-2

Identifiers

PMID33823228
PMCPMC8018909

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.